Crossmark

Nanomedicine-based co-delivery of a calcium channel inhibitor and a small molecule targeting CD47 for lung cancer immunotherapy

Crossref DOI link: https://doi.org/10.1038/s41467-023-42972-2

Published Online: 2023-11-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Guo, Yuedong https://orcid.org/0000-0002-1951-0807
Bao, Qunqun https://orcid.org/0009-0005-5134-5062
Hu, Ping https://orcid.org/0000-0002-5183-1256
Shi, Jianlin https://orcid.org/0000-0001-8790-195X
License Information

Text and Data Mining valid from 2023-11-11

Version of Record valid from 2023-11-11
More Information

Article History

Received: 10 April 2023

Accepted: 27 October 2023

First Online: 11 November 2023

Competing interests

: The authors declare no competing interests.